Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a
private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the
following information on behalf of a major shareholder and primary insider.

Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was
lent, not sold, by CEO and CFO Anders Storbråten.


The shares - 4,359,315 - is now returned to Anders Storbråten. Storbråten and
close relations hold 11,555,213 shares or 20,3 % shares of the total outstanding
shares and votes in IDEX Biometrics after completion of Tranche 2 and
underwriting shares.


IDEX Biometrics' reports and presentations are available on our website:
www.idexbiometrics.com/investors (http://www.idexbiometrics.com/investors)


For further information, please contact: Anders Storbråten, CEO and CFO, Tel:
+47 416 38 582

E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)


About IDEX Biometrics:

IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com/)


About this notice:

This notice was issued by Kjell-Arne Besseberg, COO, on 26 August 2025 at 08:50
CEST on behalf of IDEX Biometrics ASA. The information about the lending shall
be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU
596/2014). The information about shareholding shall be disclosed according to
section 4-2 of the Norwegian Securities Trading Act (STA). The information is
published in accordance with section 5-12 of the Norwegian Securities Trading
Act.